Tina Bhutani, MD
Dermatology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 18 years
- Graduated 2008
Offices
1 location · Tina Bhutani-Jacques MD Inc · 3 clinicians in this group
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bhutani’s office at (415) 333-0348 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A108915 · Current
Licensed to practise in California · since 2009 · expires 2028-11-30 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Dermatology - Dermatology
Original Medicare doctor bills
$284,727
Medicare paid this office $284,727 for 679 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 27 | $89,237 | $101 |
| Short return visit (20+ min) | 343 | $40,628 | $81 |
| Return visit (30+ min) | 259 | $37,101 | $109 |
| Destruction of precancer skin growth, 15 or more growths | 85 | $23,139 | $166 |
| Destruction of skin growth, 1-14 growths | 100 | $13,944 | $107 |
See all 14 services
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 27 | $89,237 | $101 |
| Short return visit (20+ min) | 343 | $40,628 | $81 |
| Return visit (30+ min) | 259 | $37,101 | $109 |
| Destruction of precancer skin growth, 15 or more growths | 85 | $23,139 | $166 |
| Destruction of skin growth, 1-14 growths | 100 | $13,944 | $107 |
| Biopsy of related skin growth, first growth | 118 | $12,500 | $91 |
| Destruction of precancer skin growth, 1 growth | 169 | $12,490 | $57 |
| New patient visit (45+ min) | 67 | $9,803 | $146 |
| New patient visit (30+ min) | 80 | $7,726 | $97 |
| Destruction of precancer skin growth, 2-14 growths | 140 | $6,469 | $6 |
| Punch biopsy, first skin growth | 20 | $3,113 | $130 |
| Short return visit | 55 | $3,105 | $54 |
| Biopsy of related skin growth, each additional growth | 22 | $1,255 | $45 |
| New patient visit (15+ min) | 18 | $1,196 | $66 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 20 | More than 74% of doctors who do this |
| Removal of skin cancer | 43 | More than 15% of doctors who do this |
| Removal of skin lesions | 1082 | More than 94% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 242 | More than 88% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 143 | 68 | 92 | 192 | 172 | 1,007 |
| Destruction of precancer skin growth, 1 growth | 51 | 27 | 36 | 52 | 47 | 218 |
| Biopsy of related skin growth, first growth | 38 | 25 | 29 | 32 | 38 | 138 |
| Destruction of skin growth, 1-14 growths | 42 | 24 | 20 | 35 | 24 | 130 |
| Destruction of precancer skin growth, 15 or more growths | – | – | – | – | – | 139 |
| Biopsy of related skin growth, each additional growth | 13 | – | – | – | – | 28 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
679 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 16% · Women 47% · Also on Medicaid 20% · Health risk score 1.10. Above the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 71% · Diabetes 27% · Chronic kidney disease 20% · Coronary heart disease 18% · Atrial fibrillation 16% · Cancer 14% · Depression 13% · Heart failure 11% · COPD 7% · Dementia 5% · Stroke 5%.
The office billed $741,329, Medicare allowed $368,590 and paid $284,727; for 3,826 services of 59 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 679 | 3,826 | 76 | 1.10 | $741,329 | $284,727 |
| 2023 | 235 | 795 | 74 | 1.07 | $418,849 | $35,205 |
| 2022 | 227 | 957 | 74 | 0.99 | $499,441 | $44,412 |
| 2021 | 180 | 573 | 72 | 1.06 | $284,815 | $28,332 |
| 2020 | 209 | 568 | 72 | 1.16 | $212,724 | $18,078 |
| 2019 | 276 | 980 | 72 | 1.11 | $359,265 | $31,740 |
| 2018 | 206 | 742 | 72 | 1.24 | $273,943 | $23,256 |
| 2017 | 202 | 830 | 72 | 1.24 | $246,753 | $24,740 |
| 2016 | 186 | 831 | 72 | 1.12 | $245,946 | $22,647 |
| 2015 | 80 | 301 | 71 | 1.39 | $82,464 | $9,167 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 101 | $10,523 | $74 |
| Short return visit (20+ min) | 104 | $5,572 | $46 |
| Destruction of precancer skin growth, 1 growth | 38 | $2,100 | $45 |
| New patient visit (45+ min) | 25 | $2,075 | $83 |
| New patient visit (30+ min) | 23 | $1,528 | $66 |
| Destruction of skin growth, 1-14 growths | 22 | $1,298 | $54 |
| Biopsy of related skin growth, first growth | 34 | $877 | $23 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 13 | $319 | $23 |
| Destruction of precancer skin growth, 2-14 growths | 31 | $281 | $2 |
2022: 9 services
| Return visit (30+ min) | 98 | $10,236 | $77 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 11 | $7,997 | $58 |
| Short return visit (20+ min) | 101 | $6,417 | $51 |
| New patient visit (45+ min) | 24 | $2,278 | $95 |
| Destruction of precancer skin growth, 1 growth | 42 | $2,117 | $41 |
| Destruction of skin growth, 1-14 growths | 27 | $1,897 | $54 |
| New patient visit (30+ min) | 14 | $810 | $58 |
| Biopsy of related skin growth, first growth | 27 | $725 | $23 |
| Destruction of precancer skin growth, 2-14 growths | 37 | $289 | $2 |
2021: 8 services
| Return visit (30+ min) | 62 | $7,061 | $83 |
| Short return visit (20+ min) | 83 | $4,966 | $48 |
| New patient visit (45+ min) | 22 | $2,539 | $115 |
| Destruction of precancer skin growth, 1 growth | 31 | $1,297 | $36 |
| New patient visit (30+ min) | 17 | $978 | $58 |
| Destruction of skin growth, 1-14 growths | 18 | $967 | $48 |
| Biopsy of related skin growth, first growth | 26 | $657 | $23 |
| Destruction of precancer skin growth, 2-14 growths | 22 | $165 | $2 |
2020: 7 services
| Short return visit (20+ min) | 143 | $7,849 | $38 |
| New patient visit (30+ min) | 45 | $2,282 | $51 |
| Destruction of skin growth, 1-14 growths | 20 | $1,294 | $54 |
| Destruction of precancer skin growth, 1 growth | 25 | $947 | $35 |
| Biopsy of related skin growth, first growth | 24 | $576 | $23 |
| Short return visit | 11 | $253 | $18 |
| Destruction of precancer skin growth, 2-14 growths | 17 | $102 | $1 |
2019: 9 services
| Short return visit (20+ min) | 172 | $11,123 | $41 |
| Short return visit | 19 | $4,667 | $20 |
| New patient visit (30+ min) | 58 | $3,599 | $62 |
| Destruction of skin growth, 1-14 growths | 31 | $2,694 | $64 |
| Destruction of precancer skin growth, 1 growth | 47 | $2,136 | $42 |
| Biopsy of related skin growth, first growth | 35 | $997 | $26 |
| Short return visit | 37 | $755 | $20 |
| Biopsy of related skin growth, each additional growth | 11 | $274 | $21 |
| Destruction of precancer skin growth, 2-14 growths | 34 | $273 | $2 |
2018: 8 services
| Short return visit (20+ min) | 127 | $6,997 | $39 |
| Short return visit | 18 | $4,259 | $22 |
| New patient visit (30+ min) | 33 | $1,920 | $58 |
| Destruction of skin growth, 1-14 growths | 18 | $1,272 | $61 |
| Destruction of precancer skin growth, 1 growth | 31 | $1,248 | $39 |
| Biopsy of single growth of skin and/or tissue | 33 | $1,035 | $30 |
| Short return visit | 24 | $480 | $19 |
| Destruction of precancer skin growth, 2-14 growths | 24 | $177 | $2 |
2017: 9 services
| Short return visit (20+ min) | 135 | $9,086 | $42 |
| Short return visit | 12 | $4,854 | $23 |
| New patient visit (30+ min) | 29 | $1,618 | $56 |
| Destruction of precancer skin growth, 1 growth | 36 | $1,586 | $41 |
| Short return visit | 31 | $1,395 | $19 |
| Biopsy of single growth of skin and/or tissue | 34 | $1,287 | $37 |
| Destruction of skin growth, 1-14 growths | 13 | $822 | $63 |
| Return visit (30+ min) | 11 | $704 | $64 |
| Destruction of precancer skin growth, 2-14 growths | 28 | $240 | $2 |
2016: 9 services
| Short return visit (20+ min) | 114 | $6,673 | $37 |
| Short return visit | 41 | $6,135 | $21 |
| New patient visit (30+ min) | 48 | $2,224 | $46 |
| Return visit (30+ min) | 22 | $1,822 | $63 |
| Destruction of precancer skin growth, 1 growth | 34 | $1,337 | $33 |
| Destruction of skin growth, 1-14 growths | 20 | $1,231 | $54 |
| Biopsy of single growth of skin and/or tissue | 29 | $913 | $30 |
| New patient visit (15+ min) | 11 | $310 | $28 |
| Destruction of precancer skin growth, 2-14 growths | 25 | $211 | $1 |
2015: 4 services
| Short return visit (20+ min) | 57 | $3,807 | $44 |
| Short return visit | 13 | $1,803 | $23 |
| Destruction of precancer skin growth, 1 growth | 13 | $587 | $45 |
| Destruction of precancer skin growth, 2-14 growths | 11 | $121 | $2 |
Medicaid work
$6,243 in 2024
Medicaid paid $6,243 for 99 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 56 | $3,711 |
| Short return visit (20+ min) | 31 | $1,302 |
| New patient visit (45+ min) | 12 | $1,230 |
| 2024 | 99 | 3 | 16 | $6,243 |
| 2023 | 14 | 1 | 14 | $1,221 |
| 2021 | 13 | 1 | 13 | $602 |
| 2020 | 46 | 1 | 16 | $2,009 |
| 2019 | 209 | 2 | 18 | $7,492 |
| 2018 | 64 | 2 | 14 | $2,363 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 14 | $1,221 |
2021
| Short return visit (20+ min) | 13 | $602 |
2020
| Short return visit (20+ min) | 46 | $2,009 |
2019
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 121 | $4,411 |
| Short return visit (20+ min) | 88 | $3,081 |
2018
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 38 | $1,443 |
| Short return visit (20+ min) | 26 | $920 |
Drugs they prescribed that Part D paid
$2,375,063
Pharmacies billed $2,375,063 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,521) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
1,186 generic and 335 brand-name prescriptions · $2,375,063 in drug cost · 28 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Skyrizi | 29 | $580,504 | $20,017 |
| Taltz | 51 | $368,269 | $7,221 |
| Tremfya | 23 | $281,207 | $12,226 |
| Dupixent | 51 | $219,633 | $4,307 |
| Cosentyx Unoready | 18 | $172,028 | $9,557 |
See all 33 drugs
| Skyrizi | 29 | $580,504 | $20,017 |
| Taltz | 51 | $368,269 | $7,221 |
| Tremfya | 23 | $281,207 | $12,226 |
| Dupixent | 51 | $219,633 | $4,307 |
| Cosentyx Unoready | 18 | $172,028 | $9,557 |
| Stelara | 11 | $157,266 | $14,297 |
| Otezla | 22 | $141,132 | $6,415 |
| Rinvoq | 11 | $79,251 | $7,205 |
| Siliq | 14 | $71,917 | $5,137 |
| Dupixent | 12 | $43,364 | $3,614 |
| Acitretin | 26 | $15,414 | $593 |
| Clobetasol Propionate | 176 | $7,344 | $42 |
| Desonide | 60 | $4,092 | $68 |
| Triamcinolone Acetonide | 233 | $3,530 | $15 |
| Calcipotriene | 13 | $3,356 | $258 |
| Tacrolimus | 26 | $3,113 | $120 |
| Halobetasol Propionate | 46 | $3,085 | $67 |
| Ketoconazole | 124 | $2,272 | $18 |
| Metronidazole | 44 | $1,948 | $44 |
| Fluocinonide | 62 | $1,943 | $31 |
| Betamethasone Diprop Augmented | 45 | $1,571 | $35 |
| Ciclopirox | 28 | $716 | $26 |
| Betamethasone Dipropionate | 19 | $654 | $34 |
| Clotrimazole-Betamethasone | 16 | $588 | $37 |
| Hydroxyzine | 26 | $528 | $20 |
| Fluocinolone Acetonide | 11 | $423 | $38 |
| Clindamycin Phosphate | 19 | $403 | $21 |
| Doxycycline Hyclate | 23 | $325 | $14 |
| Mometasone Furoate | 20 | $325 | $16 |
| Methotrexate | 11 | $288 | $26 |
| Hydrocortisone | 39 | $220 | $6 |
| Mupirocin | 23 | $113 | $5 |
| Gabapentin | 14 | $31 | $2 |
Year by year
| 2024 | 1,521 | 416 | 0% (0) | 22% | $2,375,063 |
| 2023 | 1,211 | 202 | 0% (0) | 22% | $2,083,756 |
| 2022 | 1,091 | 199 | 0% (0) | None | $1,941,267 |
| 2021 | 1,003 | 187 | 0% (0) | 23% | $1,556,069 |
| 2020 | 1,013 | 184 | 0% (0) | 20% | $1,111,826 |
| 2019 | 913 | 188 | 0% (0) | 22% | $931,550 |
| 2018 | 843 | 152 | None | 21% | $625,385 |
| 2017 | 625 | 145 | 0% (0) | 17% | $412,379 |
| 2016 | 607 | 136 | 0% (0) | 20% | $408,597 |
| 2015 | 178 | 67 | 0% (0) | 20% | $243,133 |
| 2014 | 101 | 38 | 0% (0) | None | $108,296 |
| 2013 | 189 | 67 | 0% (0) | None | $21,002 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Tremfya | 30 | $352,467 | $11,749 |
| Stelara | 22 | $298,157 | $13,553 |
| Skyrizi | 14 | $255,892 | $18,278 |
| Taltz | 20 | $226,168 | $11,308 |
| Otezla | 21 | $138,319 | $6,587 |
| Cosentyx Sensoready (2 Pens) | 14 | $102,931 | $7,352 |
| Dupixent | 16 | $93,002 | $5,813 |
| Enbrel | 12 | $91,359 | $7,613 |
| Dupixent | 23 | $82,248 | $3,576 |
| Siliq | 12 | $71,219 | $5,935 |
| Opzelura | 11 | $24,058 | $2,187 |
| Clobetasol Propionate | 156 | $21,407 | $137 |
| Acitretin | 39 | $18,685 | $479 |
| Calcipotriene | 19 | $7,649 | $403 |
| Desonide | 62 | $7,400 | $119 |
| Triamcinolone Acetonide | 213 | $4,755 | $22 |
| Ketoconazole | 100 | $2,435 | $24 |
| Betamethasone Dipropionate | 14 | $2,330 | $166 |
| Fluocinonide | 43 | $2,075 | $48 |
| Halobetasol Propionate | 34 | $1,722 | $51 |
| Clotrimazole-Betamethasone | 28 | $1,504 | $54 |
| Alclometasone Dipropionate | 11 | $868 | $79 |
| Clindamycin Phosphate | 24 | $843 | $35 |
| Betamethasone Diprop Augmented | 22 | $755 | $34 |
| Mometasone Furoate | 21 | $642 | $31 |
| Doxepin | 12 | $621 | $52 |
| Ciclopirox | 14 | $539 | $39 |
| Hydroxyzine | 27 | $432 | $16 |
| Fluconazole | 12 | $335 | $28 |
| Clotrimazole | 16 | $252 | $16 |
| Hydrocortisone | 22 | $167 | $8 |
2022: 26 drugs
| Stelara | 30 | $393,663 | $13,122 |
| Tremfya | 31 | $389,459 | $12,563 |
| Cosentyx Pen (2 Pens) | 22 | $235,242 | $10,693 |
| Skyrizi | 13 | $230,974 | $17,767 |
| Otezla | 25 | $161,627 | $6,465 |
| Taltz | 20 | $111,785 | $5,589 |
| Cosentyx (2 Syringes) | 12 | $71,667 | $5,972 |
| Siliq | 13 | $54,140 | $4,165 |
| Dupixent | 14 | $45,833 | $3,274 |
| Acitretin | 32 | $18,566 | $580 |
| Clobetasol Propionate | 134 | $18,009 | $134 |
| Calcipotriene | 27 | $13,130 | $486 |
| Desonide | 39 | $4,840 | $124 |
| Triamcinolone Acetonide | 205 | $4,610 | $22 |
| Halobetasol Propionate | 39 | $3,216 | $82 |
| Ketoconazole | 101 | $3,190 | $32 |
| Fluocinonide | 46 | $2,598 | $56 |
| Betamethasone Diprop Augmented | 20 | $1,366 | $68 |
| Clotrimazole-Betamethasone | 26 | $1,181 | $45 |
| Fluocinolone Acetonide | 14 | $1,070 | $76 |
| Mometasone Furoate | 25 | $875 | $35 |
| Clindamycin Phosphate | 19 | $751 | $40 |
| Nystatin | 14 | $388 | $28 |
| Hydroxyzine | 11 | $348 | $32 |
| Clotrimazole | 16 | $182 | $11 |
| Hydrocortisone | 30 | $168 | $6 |
2021: 24 drugs
| Stelara | 19 | $232,745 | $12,250 |
| Otezla | 32 | $209,211 | $6,538 |
| Tremfya | 16 | $206,945 | $12,934 |
| Dupixent | 33 | $160,835 | $4,874 |
| Siliq | 14 | $56,842 | $4,060 |
| Acitretin | 39 | $27,253 | $699 |
| Clobetasol Propionate | 155 | $15,203 | $98 |
| Calcipotriene | 16 | $7,060 | $441 |
| Triamcinolone Acetonide | 183 | $3,862 | $21 |
| Fluocinonide | 51 | $2,781 | $55 |
| Ketoconazole | 52 | $1,998 | $38 |
| Desonide | 34 | $1,872 | $55 |
| Halobetasol Propionate | 25 | $1,814 | $73 |
| Mometasone Furoate | 35 | $1,520 | $43 |
| Betamethasone Diprop Augmented | 14 | $847 | $61 |
| Clotrimazole-Betamethasone | 18 | $846 | $47 |
| Nystatin | 12 | $444 | $37 |
| Ciclopirox | 16 | $438 | $27 |
| Clindamycin Phosphate | 13 | $397 | $31 |
| Betamethasone Valerate | 11 | $395 | $36 |
| Clotrimazole | 14 | $282 | $20 |
| Doxepin | 11 | $243 | $22 |
| Mupirocin | 14 | $153 | $11 |
| Hydrocortisone | 22 | $141 | $6 |
2020: 26 drugs
| Stelara | 17 | $209,543 | $12,326 |
| Tremfya | 14 | $155,747 | $11,125 |
| Otezla | 26 | $129,677 | $4,988 |
| Enbrel | 11 | $93,951 | $8,541 |
| Humira(Cf) | 15 | $84,644 | $5,643 |
| Dupixent | 21 | $67,069 | $3,194 |
| Siliq | 16 | $56,997 | $3,562 |
| Acitretin | 36 | $28,508 | $792 |
| Clobetasol Propionate | 136 | $8,048 | $59 |
| Calcipotriene | 26 | $5,618 | $216 |
| Halobetasol Propionate | 48 | $4,967 | $103 |
| Metrogel | 11 | $4,278 | $389 |
| Triamcinolone Acetonide | 180 | $3,831 | $21 |
| Tacrolimus | 14 | $3,535 | $252 |
| Fluocinonide | 53 | $2,734 | $52 |
| Desonide | 34 | $2,669 | $79 |
| Betamethasone Diprop Augmented | 18 | $2,354 | $131 |
| Ketoconazole | 49 | $1,130 | $23 |
| Clindamycin Phosphate | 17 | $556 | $33 |
| Mometasone Furoate | 15 | $418 | $28 |
| Hydroxyzine | 19 | $410 | $22 |
| Hydrocortisone | 42 | $392 | $9 |
| Clotrimazole | 23 | $382 | $17 |
| Clotrimazole-Betamethasone | 18 | $363 | $20 |
| Nystatin | 13 | $324 | $25 |
| Mupirocin | 16 | $155 | $10 |
2019: 24 drugs
| Stelara | 16 | $250,300 | $15,644 |
| Humira | 20 | $104,664 | $5,233 |
| Otezla | 19 | $93,241 | $4,907 |
| Siliq | 13 | $43,833 | $3,372 |
| Dupixent | 11 | $34,575 | $3,143 |
| Acitretin | 34 | $23,088 | $679 |
| Clobetasol Propionate | 133 | $18,362 | $138 |
| Calcipotriene | 32 | $6,657 | $208 |
| Tacrolimus | 14 | $3,602 | $257 |
| Betamethasone Diprop Augmented | 19 | $3,542 | $186 |
| Halobetasol Propionate | 24 | $3,131 | $130 |
| Desonide | 41 | $2,868 | $70 |
| Triamcinolone Acetonide | 125 | $2,618 | $21 |
| Ketoconazole | 53 | $2,106 | $40 |
| Fluocinonide | 33 | $1,982 | $60 |
| Betamethasone Dipropionate | 20 | $1,317 | $66 |
| Methotrexate | 17 | $972 | $57 |
| Clotrimazole | 26 | $676 | $26 |
| Clotrimazole-Betamethasone | 18 | $399 | $22 |
| Clindamycin Phosphate | 13 | $377 | $29 |
| Hydrocortisone | 45 | $358 | $8 |
| Nystatin | 12 | $284 | $24 |
| Hydroxyzine | 20 | $271 | $14 |
| Mometasone Furoate | 15 | $200 | $13 |
2018: 18 drugs
| Otezla | 17 | $89,693 | $5,276 |
| Siliq | 14 | $47,830 | $3,416 |
| Clobetasol Propionate | 138 | $32,238 | $234 |
| Acitretin | 22 | $15,014 | $682 |
| Calcipotriene | 21 | $8,593 | $409 |
| Betamethasone Diprop Augmented | 20 | $5,264 | $263 |
| Halobetasol Propionate | 29 | $3,620 | $125 |
| Ketoconazole | 65 | $3,554 | $55 |
| Triamcinolone Acetonide | 142 | $3,368 | $24 |
| Desonide | 18 | $2,323 | $129 |
| Clindamycin Phosphate | 27 | $926 | $34 |
| Fluocinonide | 13 | $894 | $69 |
| Clotrimazole | 25 | $866 | $35 |
| Methotrexate | 12 | $791 | $66 |
| Clotrimazole-Betamethasone | 19 | $733 | $39 |
| Betamethasone Dipropionate | 11 | $663 | $60 |
| Hydrocortisone | 33 | $219 | $7 |
| Mupirocin | 12 | $110 | $9 |
2017: 14 drugs
| Humira | 11 | $49,467 | $4,497 |
| Clobetasol Propionate | 123 | $33,096 | $269 |
| Acitretin | 35 | $24,481 | $699 |
| Ketoconazole | 48 | $4,535 | $94 |
| Cyclosporine Modified | 13 | $3,451 | $265 |
| Triamcinolone Acetonide | 104 | $2,360 | $23 |
| Desonide | 12 | $2,255 | $188 |
| Fluocinonide | 22 | $1,927 | $88 |
| Halobetasol Propionate | 13 | $1,738 | $134 |
| Metronidazole | 12 | $1,689 | $141 |
| Methotrexate | 12 | $986 | $82 |
| Betamethasone Dipropionate | 15 | $896 | $60 |
| Clindamycin Phosphate | 15 | $522 | $35 |
| Hydrocortisone | 13 | $95 | $7 |
2016: 9 drugs
| Clobetasol Propionate | 133 | $39,526 | $297 |
| Acitretin | 36 | $22,418 | $623 |
| Calcipotriene | 17 | $10,427 | $613 |
| Triamcinolone Acetonide | 120 | $4,083 | $34 |
| Desonide | 21 | $3,802 | $181 |
| Cyclosporine Modified | 11 | $2,100 | $191 |
| Ketoconazole | 52 | $2,049 | $39 |
| Fluocinonide | 16 | $1,290 | $81 |
| Hydroxyzine | 12 | $203 | $17 |
2015: 3 drugs
| Clobetasol Propionate | 37 | $13,304 | $360 |
| Fluocinonide | 17 | $1,215 | $71 |
| Triamcinolone Acetonide | 29 | $1,153 | $40 |
2014: 3 drugs
| Clobetasol Propionate | 16 | $1,770 | $111 |
| Fluocinonide | 11 | $687 | $62 |
| Dexamethasone | 11 | $335 | $30 |
2013: 2 drugs
| Clobetasol Propionate | 46 | $1,815 | $39 |
| Triamcinolone Acetonide | 15 | $398 | $27 |
Money from drug and device companies
$595,797 in 2025
| 2025 | 24 | 671 | $543,537 | $595,797 |
| 2024 | 27 | 450 | $252,952 | $287,239 |
| 2023 | 16 | 99 | $89,439 | $98,171 |
| 2022 | 12 | 38 | $32,488 | $35,181 |
| 2021 | 6 | 15 | $19,485 | $19,532 |
| 2020 | 8 | 11 | $28,874 | $28,874 |
| 2019 | 4 | 29 | $5,950 | $7,364 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $100,991 | 99 payments
|
| Genzyme | Dupixent | $86,641 | 48 payments
|
| Arcutis Biotherapeutics | Zoryve | $74,094 | 71 payments
|
| Lilly USA | Ebglyss | $72,217 | 71 payments
|
| Abbvie | Skyrizi | $57,933 | 73 payments
|
| Galderma Laboratories L.P. | Nemluvio | $52,112 | 64 payments
|
See all 668 published payments
| Abbvie | Paid to speak or teach · 2025-12-30 | Skyrizi | $3,500 |
| Abbvie | Paid to speak or teach · 2025-12-30 | Skyrizi | $3,500 |
| Galderma Laboratories L.P. | Travel · 2025-12-29 | Nemluvio | $10 |
| Galderma Laboratories L.P. | Travel · 2025-12-29 | Nemluvio | $109 |
| Galderma Laboratories L.P. | Travel · 2025-12-29 | Nemluvio | $40 |
| Galderma Laboratories L.P. | Travel · 2025-12-29 | Nemluvio | $24 |
| Galderma Laboratories L.P. | Travel · 2025-12-29 | Nemluvio | $8 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-12-22 | Siliq | $24 |
| Novartis Pharmaceuticals | Consulting · 2025-12-19 | Cosentyx | $2,250 |
| Arcutis Biotherapeutics | Consulting · 2025-12-19 | Zoryve | $3,375 |
| Galderma Laboratories L.P. | Consulting · 2025-12-18 | Nemluvio | $13,600 |
| Novartis Pharmaceuticals | Meals · 2025-12-17 | Rhapsido | $27 |
| Abbvie | Meals · 2025-12-17 | Skyrizi | $23 |
| Abbvie | Paid to speak or teach · 2025-12-17 | Rinvoq | $3,500 |
| Incyte | Meals · 2025-12-16 | Opzelura | $19 |
| Abbvie | Meals · 2025-12-15 | Rinvoq | $16 |
| Genzyme | Meals · 2025-12-15 | Dupixent | $18 |
| LEO Pharma | Meals · 2025-12-15 | Anzupgo | $21 |
| Galderma Laboratories L.P. | Travel · 2025-12-12 | Nemluvio | $704 |
| Galderma Laboratories L.P. | Travel · 2025-12-12 | Nemluvio | $248 |
| Galderma Laboratories L.P. | Meals · 2025-12-12 | Nemluvio | $27 |
| Galderma Laboratories L.P. | Meals · 2025-12-12 | Nemluvio | $49 |
| Galderma Laboratories L.P. | Meals · 2025-12-12 | Nemluvio | $20 |
| Abbvie | Meals · 2025-12-11 | Skyrizi | $32 |
| Abbvie | Meals · 2025-12-11 | Skyrizi | $34 |
| Abbvie | Travel · 2025-12-11 | Skyrizi | $569 |
| Abbvie | Paid to speak or teach · 2025-12-11 | Rinvoq | $3,500 |
| Ucb | Travel · 2025-12-11 | Bimzelx | $8 |
| Ucb | Paid to speak or teach · 2025-12-11 | Bimzelx | $4,500 |
| Ucb | Meals · 2025-12-10 | Bimzelx | $23 |
| Arcutis Biotherapeutics | Consulting · 2025-12-10 | Zoryve | $3,375 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-12-09 | Siliq | $17 |
| LEO Pharma | Meals · 2025-12-09 | Adbry | $18 |
| LEO Pharma | Meals · 2025-12-09 | Adbry | $18 |
| Organon | Meals · 2025-12-08 | Vtama | $17 |
| Arcutis Biotherapeutics | Meals · 2025-12-06 | Zoryve | $142 |
| Arcutis Biotherapeutics | Travel · 2025-12-05 | Zoryve | $12 |
| Arcutis Biotherapeutics | Meals · 2025-12-05 | Zoryve | $7 |
| Arcutis Biotherapeutics | Consulting · 2025-12-03 | Zoryve | $3,375 |
| Incyte | Meals · 2025-12-02 | Opzelura | $14 |
| Pfizer | Meals · 2025-12-02 | Litfulo | $28 |
| Abbvie | Meals · 2025-12-01 | Rinvoq | $14 |
| Regeneron Healthcare Solutions | Meals · 2025-12-01 | Dupixent | $8 |
| Galderma Laboratories L.P. | Travel · 2025-12-01 | Nemluvio | $48 |
| Galderma Laboratories L.P. | Meals · 2025-12-01 | Nemluvio | $21 |
| Arcutis Biotherapeutics | Meals · 2025-12-01 | Zoryve | $36 |
| Galderma Laboratories L.P. | Travel · 2025-11-25 | Nemluvio | $32 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-11-24 | Siliq | $58 |
| Arcutis Biotherapeutics | Consulting · 2025-11-24 | Zoryve | $750 |
| Galderma Laboratories L.P. | Paid to speak or teach · 2025-11-21 | Nemluvio | $3,600 |
| Galderma Laboratories L.P. | Paid to speak or teach · 2025-11-21 | Nemluvio | $3,600 |
| Abbvie | Paid to speak or teach · 2025-11-20 | Skyrizi | $4,900 |
| Abbvie | Paid to speak or teach · 2025-11-20 | Skyrizi | $3,500 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-11-20 | None | $3,591 |
| Ucb | Meals · 2025-11-19 | Bimzelx | $20 |
| Ucb | Meals · 2025-11-19 | Bimzelx | $125 |
| Galderma Laboratories L.P. | Meals · 2025-11-19 | Nemluvio | $27 |
| LEO Pharma | Meals · 2025-11-19 | Anzupgo | $14 |
| Incyte | Meals · 2025-11-18 | Opzelura | $29 |
| Pfizer | Meals · 2025-11-18 | Litfulo | $18 |
| Janssen Biotech | Meals · 2025-11-16 | Tremfya | $34 |
| Abbvie | Consulting · 2025-11-14 | Skyrizi | $775 |
| Regeneron Healthcare Solutions | Meals · 2025-11-14 | Dupixent | $22 |
| Genzyme | Meals · 2025-11-14 | Dupixent | $25 |
| Genzyme | Paid to speak or teach · 2025-11-14 | Dupixent | $5,253 |
| Genzyme | Travel · 2025-11-14 | Dupixent | $28 |
| Arcutis Biotherapeutics | Consulting · 2025-11-14 | Zoryve | $750 |
| Arcutis Biotherapeutics | Meals · 2025-11-14 | Zoryve | $6 |
| Arcutis Biotherapeutics | Travel · 2025-11-14 | Zoryve | $35 |
| Arcutis Biotherapeutics | Travel · 2025-11-14 | Zoryve | $43 |
| Abbvie | Meals · 2025-11-13 | Skyrizi | $17 |
| Galderma Laboratories L.P. | Meals · 2025-11-13 | Nemluvio | $22 |
| Incyte | Meals · 2025-11-12 | Opzelura | $24 |
| Arcutis Biotherapeutics | Meals · 2025-11-08 | Zoryve | $129 |
| Abbvie | Paid to speak or teach · 2025-11-07 | Rinvoq | $4,900 |
| Galderma Laboratories L.P. | Paid to speak or teach · 2025-11-07 | Nemluvio | $2,250 |
| Arcutis Biotherapeutics | Consulting · 2025-11-07 | Zoryve | $3,375 |
| Abbvie | Travel · 2025-11-06 | Skyrizi | $250 |
| Abbvie | Meals · 2025-11-06 | Skyrizi | $117 |
| Abbvie | Travel · 2025-11-06 | Skyrizi | $175 |
| Abbvie | Meals · 2025-11-06 | Skyrizi | $33 |
| Abbvie | Travel · 2025-11-06 | Skyrizi | $3,277 |
| Organon | Honoraria · 2025-11-06 | Vtama | $3,200 |
| Arcutis Biotherapeutics | Travel · 2025-11-06 | Zoryve | $783 |
| Novartis Pharmaceuticals | Meals · 2025-11-05 | Rhapsido | $30 |
| Arcutis Biotherapeutics | Consulting · 2025-11-05 | Zoryve | $3,375 |
| Arcutis Biotherapeutics | Consulting · 2025-11-05 | Zoryve | $5,625 |
| Abbvie | Meals · 2025-11-04 | Rinvoq | $15 |
| LEO Pharma | Meals · 2025-11-04 | Anzupgo | $53 |
| Arcutis Biotherapeutics | Meals · 2025-11-04 | Zoryve | $31 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-11-03 | Siliq | $21 |
| Eli Lilly and | Consulting · 2025-10-30 | Taltz | $800 |
| Amgen | Paid to speak or teach · 2025-10-30 | None | $4,800 |
| Eli Lilly and | Paid to speak or teach · 2025-10-29 | Taltz | $3,200 |
| Eli Lilly and | Paid to speak or teach · 2025-10-29 | Taltz | $2,800 |
| Genzyme | Meals · 2025-10-29 | Dupixent | $33 |
| Galderma Laboratories L.P. | Meals · 2025-10-29 | Nemluvio | $28 |
| LEO Pharma | Meals · 2025-10-29 | Spevigo | $6 |
| LEO Pharma | Meals · 2025-10-29 | Spevigo | $5 |
| LEO Pharma | Meals · 2025-10-29 | Spevigo | $7 |
| Arcutis Biotherapeutics | Consulting · 2025-10-29 | Zoryve | $7,125 |
| Arcutis Biotherapeutics | Meals · 2025-10-29 | Zoryve | $69 |
| Arcutis Biotherapeutics | Meals · 2025-10-29 | Zoryve | $10 |
| Arcutis Biotherapeutics | Meals · 2025-10-29 | Zoryve | $76 |
| Abbvie | Paid to speak or teach · 2025-10-28 | Skyrizi | $3,500 |
| Amgen | Meals · 2025-10-28 | Otezla | $15 |
| Galderma Laboratories L.P. | Travel · 2025-10-28 | Nemluvio | $12 |
| Galderma Laboratories L.P. | Meals · 2025-10-28 | Nemluvio | $24 |
| LEO Pharma | Meals · 2025-10-28 | Anzupgo | $5 |
| LEO Pharma | Meals · 2025-10-28 | Anzupgo | $3 |
| Janssen Biotech | Meals · 2025-10-27 | Tremfya | $9 |
| Lilly USA | Meals · 2025-10-27 | Taltz | $15 |
| Incyte | Meals · 2025-10-25 | Opzelura | $139 |
| Arcutis Biotherapeutics | Meals · 2025-10-25 | Zoryve | $25 |
| Arcutis Biotherapeutics | Meals · 2025-10-25 | Zoryve | $46 |
| Regeneron Healthcare Solutions | Meals · 2025-10-24 | Dupixent | $56 |
| Galderma Laboratories L.P. | Paid to speak or teach · 2025-10-24 | Nemluvio | $3,600 |
| Janssen Biotech | Meals · 2025-10-23 | Tremfya | $110 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-23 | Sotyktu | $20 |
| Amgen | Meals · 2025-10-23 | Otezla | $43 |
| Eli Lilly and | Paid to speak or teach · 2025-10-22 | Taltz | $800 |
| Abbvie | Meals · 2025-10-22 | Rinvoq | $15 |
| Arcutis Biotherapeutics | Meals · 2025-10-22 | Zoryve | $28 |
| Arcutis Biotherapeutics | Meals · 2025-10-22 | Zoryve | $22 |
| Incyte | Meals · 2025-10-21 | Opzelura | $25 |
| Galderma Laboratories L.P. | Meals · 2025-10-21 | Nemluvio | $13 |
| Janssen Biotech | Paid to speak or teach · 2025-10-18 | Tremfya | $6,300 |
| Arcutis Biotherapeutics | Travel · 2025-10-18 | Zoryve | $1,023 |
| Arcutis Biotherapeutics | Consulting · 2025-10-17 | Zoryve | $3,375 |
| Kowa Pharmaceuticals America | Paid to speak or teach · 2025-10-16 | Zoryve | $750 |
| Arcutis Biotherapeutics | Travel · 2025-10-16 | Zoryve | $1,146 |
| Janssen Biotech | Travel · 2025-10-15 | Tremfya | $373 |
| Janssen Biotech | Travel · 2025-10-15 | Tremfya | $8 |
| Janssen Biotech | Meals · 2025-10-15 | Tremfya | $12 |
| Janssen Biotech | Meals · 2025-10-15 | Tremfya | $48 |
| Janssen Biotech | Meals · 2025-10-15 | Tremfya | $15 |
| Janssen Biotech | Meals · 2025-10-15 | Tremfya | $11 |
| Abbvie | Meals · 2025-10-15 | Skyrizi | $107 |
| Ucb | Travel · 2025-10-15 | Bimzelx | $35 |
| Ucb | Paid to speak or teach · 2025-10-15 | Bimzelx | $4,500 |
| Pfizer | Meals · 2025-10-15 | Litfulo | $28 |
| Arcutis Biotherapeutics | Travel · 2025-10-15 | Zoryve | $67 |
| Arcutis Biotherapeutics | Meals · 2025-10-15 | Zoryve | $32 |
| Arcutis Biotherapeutics | Meals · 2025-10-15 | Zoryve | $43 |
| Arcutis Biotherapeutics | Meals · 2025-10-15 | Zoryve | $125 |
| Arcutis Biotherapeutics | Travel · 2025-10-15 | Zoryve | $67 |
| Arcutis Biotherapeutics | Travel · 2025-10-15 | Zoryve | $67 |
| Abbvie | Paid to speak or teach · 2025-10-14 | Skyrizi | $2,100 |
| LEO Pharma | Meals · 2025-10-14 | Adbry | $16 |
| Arcutis Biotherapeutics | Consulting · 2025-10-13 | Zoryve | $3,375 |
| Janssen Biotech | Paid to speak or teach · 2025-10-11 | Tremfya | $6,300 |
| Janssen Biotech | Travel · 2025-10-10 | Tremfya | $282 |
| Janssen Biotech | Travel · 2025-10-09 | Tremfya | $856 |
| Janssen Biotech | Meals · 2025-10-09 | Tremfya | $145 |
| Janssen Biotech | Travel · 2025-10-09 | Tremfya | $714 |
| Novartis Pharmaceuticals | Meals · 2025-10-08 | Rhapsido | $31 |
| Novartis Pharmaceuticals | Meals · 2025-10-08 | Rhapsido | $4 |
| Incyte | Meals · 2025-10-08 | Opzelura | $9 |
| Genzyme | Meals · 2025-10-08 | Dupixent | $26 |
| Arcutis Biotherapeutics | Consulting · 2025-10-08 | Zoryve | $3,375 |
| Galderma Laboratories L.P. | Meals · 2025-10-07 | Nemluvio | $14 |
| Sun Pharmaceutical Industries | Meals · 2025-10-07 | Ilumya | $25 |
| Ucb | Paid to speak or teach · 2025-10-06 | Bimzelx | $1,660 |
| LEO Pharma | Meals · 2025-10-06 | Anzupgo | $7 |
| LEO Pharma | Meals · 2025-10-06 | Anzupgo | $6 |
| Arcutis Biotherapeutics | Travel · 2025-10-06 | Zoryve | $668 |
| Janssen Biotech | Meals · 2025-10-05 | Tremfya | $25 |
| Janssen Biotech | Paid to speak or teach · 2025-10-03 | Tremfya | $4,050 |
| LEO Pharma | Consulting · 2025-10-02 | Anzupgo | $1,200 |
| Arcutis Biotherapeutics | Meals · 2025-10-01 | Zoryve | $15 |
| Arcutis Biotherapeutics | Meals · 2025-10-01 | Zoryve | $15 |
| Ucb | Meals · 2025-09-30 | Bimzelx | $6 |
| Ucb | Meals · 2025-09-30 | Bimzelx | $7 |
| Janssen Biotech | Meals · 2025-09-29 | Tremfya | $25 |
| E.R. Squibb & Sons L.L.C. | Paid to speak or teach · 2025-09-29 | Sotyktu | $10,575 |
| Genzyme | Meals · 2025-09-29 | Dupixent | $83 |
| Genzyme | Paid to speak or teach · 2025-09-29 | Dupixent | $8,118 |
| Genzyme | Travel · 2025-09-29 | Dupixent | $794 |
| Arcutis Biotherapeutics | Meals · 2025-09-29 | Zoryve | $28 |
| Arcutis Biotherapeutics | Meals · 2025-09-29 | Zoryve | $12 |
| Genzyme | Meals · 2025-09-26 | Dupixent | $26 |
| Genzyme | Paid to speak or teach · 2025-09-26 | Dupixent | $5,253 |
| Arcutis Biotherapeutics | Consulting · 2025-09-26 | Zoryve | $3,375 |
| Lilly USA | Travel · 2025-09-24 | Ebglyss | $115 |
| Lilly USA | Meals · 2025-09-24 | Ebglyss | $7 |
| Lilly USA | Travel · 2025-09-24 | Ebglyss | $130 |
| Lilly USA | Travel · 2025-09-24 | Ebglyss | $70 |
| Lilly USA | Travel · 2025-09-24 | Ebglyss | $68 |
| Abbvie | Meals · 2025-09-24 | Skyrizi | $13 |
| Regeneron Healthcare Solutions | Meals · 2025-09-24 | Dupixent | $40 |
| Genzyme | Meals · 2025-09-24 | Dupixent | $107 |
| Genzyme | Paid to speak or teach · 2025-09-24 | Dupixent | $5,253 |
| Genzyme | Travel · 2025-09-24 | Dupixent | $802 |
| Arcutis Biotherapeutics | Meals · 2025-09-24 | Zoryve | $14 |
| Arcutis Biotherapeutics | Travel · 2025-09-24 | Zoryve | $20 |
| Janssen Biotech | Meals · 2025-09-23 | Tremfya | $14 |
| Janssen Biotech | Travel · 2025-09-23 | Tremfya | $122 |
| Janssen Biotech | Meals · 2025-09-23 | Tremfya | $7 |
| Janssen Biotech | Meals · 2025-09-23 | Tremfya | $25 |
| Ucb | Meals · 2025-09-23 | Bimzelx | $104 |
| Ucb | Travel · 2025-09-23 | Bimzelx | $552 |
| Incyte | Meals · 2025-09-23 | Opzelura | $13 |
| Pfizer | Meals · 2025-09-23 | Litfulo | $26 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-09-22 | Siliq | $17 |
| Organon | Meals · 2025-09-22 | Vtama | $1 |
| Organon | Meals · 2025-09-22 | Vtama | $17 |
| Janssen Biotech | Paid to speak or teach · 2025-09-20 | Tremfya | $6,300 |
| Janssen Biotech | Meals · 2025-09-19 | Tremfya | $60 |
| Janssen Biotech | Meals · 2025-09-19 | Tremfya | $146 |
| Janssen Biotech | Travel · 2025-09-19 | Tremfya | $893 |
| Ucb | Travel · 2025-09-19 | Bimzelx | $15 |
| Arcutis Biotherapeutics | Meals · 2025-09-19 | Zoryve | $162 |
| Arcutis Biotherapeutics | Consulting · 2025-09-19 | Zoryve | $3,375 |
| Lilly USA | Travel · 2025-09-18 | Ebglyss | $108 |
| Lilly USA | Travel · 2025-09-18 | Ebglyss | $45 |
| Lilly USA | Travel · 2025-09-18 | Ebglyss | $150 |
| Lilly USA | Travel · 2025-09-18 | Ebglyss | $283 |
| Lilly USA | Meals · 2025-09-18 | Ebglyss | $40 |
| Lilly USA | Meals · 2025-09-18 | Ebglyss | $26 |
| Abbvie | Paid to speak or teach · 2025-09-17 | Skyrizi | $3,500 |
| Genzyme | Meals · 2025-09-17 | Dupixent | $130 |
| Genzyme | Paid to speak or teach · 2025-09-17 | Dupixent | $5,320 |
| Genzyme | Travel · 2025-09-17 | Dupixent | $19 |
| Genzyme | Travel · 2025-09-17 | Dupixent | $14 |
| Arcutis Biotherapeutics | Meals · 2025-09-17 | Zoryve | $117 |
| Abbvie | Meals · 2025-09-16 | Rinvoq | $33 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-09-16 | Siliq | $23 |
| LEO Pharma | Meals · 2025-09-16 | Adbry | $13 |
| Lilly USA | Paid to speak or teach · 2025-09-15 | Ebglyss | $3,200 |
| Lilly USA | Paid to speak or teach · 2025-09-15 | Ebglyss | $2,800 |
| Incyte | Meals · 2025-09-15 | Opzelura | $26 |
| LEO Pharma | Education · 2025-09-15 | None | $50 |
| Boehringer Ingelheim Pharmaceuticals | Paid to speak or teach · 2025-09-12 | Spevigo | $2,500 |
| Genzyme | Paid to speak or teach · 2025-09-12 | Dupixent | $11,938 |
| Lilly USA | Meals · 2025-09-11 | Ebglyss | $10 |
| Lilly USA | Meals · 2025-09-11 | Ebglyss | $21 |
| Amgen | Meals · 2025-09-11 | Otezla | $139 |
| Lilly USA | Paid to speak or teach · 2025-09-09 | Ebglyss | $3,200 |
| Lilly USA | Paid to speak or teach · 2025-09-09 | Ebglyss | $3,200 |
| Lilly USA | Paid to speak or teach · 2025-09-09 | Ebglyss | $2,000 |
| Galderma Laboratories L.P. | Meals · 2025-09-09 | Nemluvio | $11 |
| Arcutis Biotherapeutics | Meals · 2025-09-09 | Zoryve | $23 |
| Janssen Scientific Affairs | Consulting · 2025-09-08 | Tremfya | $1,488 |
| Ucb | Meals · 2025-09-08 | Bimzelx | $15 |
| Amgen | Meals · 2025-09-08 | Otezla | $24 |
| Lilly USA | Travel · 2025-09-06 | None | $1,296 |
| Lilly USA | Meals · 2025-09-06 | Ebglyss | $9 |
| Pfizer | Meals · 2025-09-06 | Cibinqo | $39 |
| Lilly USA | Travel · 2025-09-05 | None | $1,332 |
| Amgen | Meals · 2025-09-05 | Otezla | $33 |
| Genzyme | Meals · 2025-09-05 | Dupixent | $101 |
| Incyte | Meals · 2025-09-04 | Opzelura | $9 |
| Novartis Pharmaceuticals | Meals · 2025-09-03 | Cosentyx | $29 |
| Novartis Pharmaceuticals | Meals · 2025-09-03 | Cosentyx | $5 |
| Abbvie | Meals · 2025-09-03 | Skyrizi | $127 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-09-03 | None | $798 |
| Incyte | Meals · 2025-09-02 | Opzelura | $29 |
| Lilly USA | Paid to speak or teach · 2025-08-29 | Ebglyss | $3,200 |
| Lilly USA | Paid to speak or teach · 2025-08-29 | Ebglyss | $2,800 |
| Arcutis Biotherapeutics | Consulting · 2025-08-29 | Zoryve | $2,625 |
| E.R. Squibb & Sons L.L.C. | Paid to speak or teach · 2025-08-26 | Sotyktu | $2,350 |
| Ucb | Travel · 2025-08-26 | Bimzelx | $78 |
| Ucb | Paid to speak or teach · 2025-08-26 | Bimzelx | $4,500 |
| LEO Pharma | Meals · 2025-08-26 | Adbry | $18 |
| Janssen Biotech | Travel · 2025-08-25 | Tremfya | $50 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-25 | Spevigo | $30 |
| Janssen Biotech | Paid to speak or teach · 2025-08-23 | Tremfya | $4,050 |
| Arcutis Biotherapeutics | Travel · 2025-08-22 | Zoryve | $90 |
| Genzyme | Paid to speak or teach · 2025-08-21 | Dupixent | $8,118 |
| Genzyme | Travel · 2025-08-21 | Dupixent | $1,902 |
| Genzyme | Meals · 2025-08-21 | Dupixent | $125 |
| Genzyme | Paid to speak or teach · 2025-08-21 | Dupixent | $5,253 |
| Genzyme | Travel · 2025-08-21 | Dupixent | $171 |
| Galderma Laboratories L.P. | Meals · 2025-08-21 | Nemluvio | $25 |
| Janssen Biotech | Meals · 2025-08-20 | Tremfya | $147 |
| Janssen Biotech | Travel · 2025-08-20 | Tremfya | $730 |
| Incyte | Meals · 2025-08-20 | Opzelura | $10 |
| Abbvie | Meals · 2025-08-19 | Rinvoq | $20 |
| Janssen Biotech | Meals · 2025-08-18 | Tremfya | $24 |
| Genzyme | Meals · 2025-08-18 | Dupixent | $17 |
| Genzyme | Meals · 2025-08-18 | Dupixent | $36 |
| Arcutis Biotherapeutics | Travel · 2025-08-15 | Zoryve | $143 |
| Arcutis Biotherapeutics | Travel · 2025-08-15 | Zoryve | $271 |
| Incyte | Meals · 2025-08-14 | Opzelura | $11 |
| Lilly USA | Travel · 2025-08-13 | Ebglyss | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-08-13 | Dupixent | $17 |
| Amgen | Meals · 2025-08-13 | Otezla | $30 |
| Genzyme | Meals · 2025-08-13 | Dupixent | $80 |
| Genzyme | Paid to speak or teach · 2025-08-13 | Dupixent | $5,253 |
| Lilly USA | Travel · 2025-08-12 | Ebglyss | $56 |
| Lilly USA | Paid to speak or teach · 2025-08-12 | Ebglyss | $3,200 |
| Lilly USA | Paid to speak or teach · 2025-08-12 | Ebglyss | $3,200 |
| Lilly USA | Paid to speak or teach · 2025-08-12 | Ebglyss | $2,000 |
| Galderma Laboratories L.P. | Travel · 2025-08-12 | Nemluvio | $45 |
| Galderma Laboratories L.P. | Meals · 2025-08-12 | None | $11 |
| Pfizer | Meals · 2025-08-11 | Litfulo | $22 |
| Arcutis Biotherapeutics | Meals · 2025-08-11 | Zoryve | $28 |
| Lilly USA | Meals · 2025-08-09 | Ebglyss | $22 |
| Arcutis Biotherapeutics | Consulting · 2025-08-09 | Zoryve | $4,688 |
| Lilly USA | Meals · 2025-08-08 | Ebglyss | $33 |
| Galderma Laboratories L.P. | Travel · 2025-08-08 | Nemluvio | $79 |
| Galderma Laboratories L.P. | Paid to speak or teach · 2025-08-08 | Nemluvio | $3,600 |
| Galderma Laboratories L.P. | Paid to speak or teach · 2025-08-08 | Nemluvio | $5,400 |
| LEO Pharma | Paid to speak or teach · 2025-08-07 | Anzupgo | $4,073 |
| Abbvie | Meals · 2025-08-06 | Skyrizi | $12 |
| Ucb | Meals · 2025-08-06 | Bimzelx | $25 |
| Incyte | Meals · 2025-08-06 | Opzelura | $28 |
| Galderma Laboratories L.P. | Meals · 2025-08-05 | Nemluvio | $13 |
| Janssen Biotech | Travel · 2025-08-04 | Tremfya | $24 |
| Janssen Biotech | Travel · 2025-08-04 | Tremfya | $25 |
| Novartis Pharmaceuticals | Meals · 2025-08-04 | Cosentyx | $13 |
| Galderma Laboratories L.P. | Paid to speak or teach · 2025-08-04 | Nemluvio | $600 |
| Janssen Biotech | Paid to speak or teach · 2025-08-02 | Tremfya | $4,050 |
| Janssen Biotech | Paid to speak or teach · 2025-08-02 | Tremfya | $4,050 |
| Janssen Biotech | Meals · 2025-08-01 | Tremfya | $29 |
| Janssen Biotech | Travel · 2025-07-30 | Tremfya | $777 |
| Janssen Biotech | Meals · 2025-07-30 | Tremfya | $111 |
| Incyte | Meals · 2025-07-30 | Opzelura | $28 |
| Galderma Laboratories L.P. | Meals · 2025-07-29 | Nemluvio | $150 |
| Arcutis Biotherapeutics | Consulting · 2025-07-28 | Zoryve | $3,000 |
| Arcutis Biotherapeutics | Meals · 2025-07-26 | Zoryve | $24 |
| LEO Pharma | Meals · 2025-07-24 | Adbry | $38 |
| Abbvie | Consulting · 2025-07-23 | None | $775 |
| Abbvie | Consulting · 2025-07-23 | None | $775 |
| Abbvie | Consulting · 2025-07-23 | Skyrizi | $775 |
| Galderma Laboratories L.P. | Meals · 2025-07-23 | Nemluvio | $25 |
| Janssen Biotech | Meals · 2025-07-22 | Tremfya | $31 |
| LEO Pharma | Meals · 2025-07-22 | Anzupgo | $146 |
| Lilly USA | Meals · 2025-07-21 | Taltz | $16 |
| Abbvie | Meals · 2025-07-21 | Skyrizi | $12 |
| Lilly USA | Paid to speak or teach · 2025-07-18 | Ebglyss | $1,600 |
| Ucb | Meals · 2025-07-18 | None | $15 |
| Galderma Laboratories L.P. | Travel · 2025-07-18 | Nemluvio | $28 |
| Galderma Laboratories L.P. | Paid to speak or teach · 2025-07-18 | Nemluvio | $3,600 |
| Genzyme | Paid to speak or teach · 2025-07-17 | Dupixent | $6,208 |
| Genzyme | Travel · 2025-07-17 | Dupixent | $830 |
| Abbvie | Meals · 2025-07-15 | Rinvoq | $34 |
| Janssen Biotech | Meals · 2025-07-14 | Tremfya | $23 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-07-14 | Siliq | $14 |
| Genzyme | Meals · 2025-07-14 | Dupixent | $21 |
| Galderma Laboratories L.P. | Meals · 2025-07-10 | Nemluvio | $24 |
| Abbvie | Meals · 2025-07-09 | Skyrizi | $24 |
| Organon | Meals · 2025-07-09 | Vtama | $17 |
| Arcutis Biotherapeutics | Meals · 2025-07-09 | Zoryve | $20 |
| Galderma Laboratories L.P. | Meals · 2025-07-08 | None | $14 |
| Ucb | Meals · 2025-07-07 | Bimzelx | $15 |
| Amgen | Meals · 2025-07-07 | Otezla | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-07-01 | Dupixent | $19 |
| Incyte | Meals · 2025-07-01 | Opzelura | $18 |
| Galderma Laboratories L.P. | Meals · 2025-07-01 | Nemluvio | $18 |
| Janssen Biotech | Meals · 2025-06-30 | Tremfya | $27 |
| Lilly USA | Paid to speak or teach · 2025-06-30 | Ebglyss | $2,800 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-06-30 | Siliq | $23 |
| Genzyme | Paid to speak or teach · 2025-06-30 | Dupixent | $955 |
| Genzyme | Paid to speak or teach · 2025-06-30 | Dupixent | $1,910 |
| Genzyme | Paid to speak or teach · 2025-06-27 | Dupixent | $5,253 |
| Genzyme | Meals · 2025-06-26 | Dupixent | $131 |
| Genzyme | Meals · 2025-06-26 | Dupixent | $111 |
| Genzyme | Paid to speak or teach · 2025-06-26 | Dupixent | $6,208 |
| Genzyme | Travel · 2025-06-26 | Dupixent | $408 |
| Abbvie | Meals · 2025-06-25 | Rinvoq | $34 |
| Novartis Pharmaceuticals | Meals · 2025-06-24 | None | $31 |
| Abbvie | Meals · 2025-06-24 | Skyrizi | $17 |
| Janssen Biotech | Meals · 2025-06-23 | Tremfya | $17 |
| Pfizer | Meals · 2025-06-23 | Litfulo | $24 |
| Genzyme | Meals · 2025-06-23 | Dupixent | $6 |
| Ucb | Travel · 2025-06-20 | Bimzelx | $15 |
| Ucb | Paid to speak or teach · 2025-06-20 | Bimzelx | $4,500 |
| Ortho Dermatologics a division of Bausch Health US | Paid to speak or teach · 2025-06-16 | Siliq | $8,100 |
| Ortho Dermatologics a division of Bausch Health US | Paid to speak or teach · 2025-06-16 | Siliq | $1,800 |
| Abbvie | Meals · 2025-06-11 | Skyrizi | $9 |
| Ucb | Meals · 2025-06-11 | Bimzelx | $27 |
| Janssen Biotech | Travel · 2025-06-10 | Tremfya | $77 |
| LEO Pharma | Meals · 2025-06-09 | Adbry | $14 |
| Arcutis Biotherapeutics | Meals · 2025-06-09 | Zoryve | $17 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-07 | Sotyktu | $31 |
| Ucb | Meals · 2025-06-07 | Bimzelx | $36 |
| Janssen Biotech | Paid to speak or teach · 2025-06-06 | Tremfya | $525 |
| Ortho Dermatologics a division of Bausch Health US | Travel · 2025-06-06 | Siliq | $62 |
| Ortho Dermatologics a division of Bausch Health US | Travel · 2025-06-05 | Siliq | $15 |
| Ortho Dermatologics a division of Bausch Health US | Travel · 2025-06-05 | Siliq | $67 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-06-05 | Siliq | $116 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-06-05 | Siliq | $7 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-06-05 | Siliq | $7 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-06-05 | Siliq | $24 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-06-05 | Siliq | $8 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-06-05 | Siliq | $22 |
| Ortho Dermatologics a division of Bausch Health US | Travel · 2025-06-05 | Siliq | $245 |
| Ortho Dermatologics a division of Bausch Health US | Travel · 2025-06-05 | Siliq | $46 |
| LEO Pharma | Paid to speak or teach · 2025-06-05 | Adbry | $4,073 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-04 | Spevigo | $15 |
| Ucb | Meals · 2025-06-04 | Bimzelx | $1 |
| Ucb | Meals · 2025-06-04 | Bimzelx | $125 |
| Pfizer | Meals · 2025-06-04 | Litfulo | $20 |
| Pfizer | Meals · 2025-06-04 | Litfulo | $31 |
| Organon | Travel · 2025-06-04 | Vtama | $53 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-06-03 | Siliq | $15 |
| Ucb | Meals · 2025-06-03 | Bimzelx | $15 |
| Incyte | Meals · 2025-06-03 | Opzelura | $24 |
| Galderma Laboratories L.P. | Meals · 2025-06-03 | None | $20 |
| Abbvie | Consulting · 2025-06-02 | Skyrizi | $775 |
| Incyte | Meals · 2025-06-02 | Opzelura | $3 |
| Galderma Laboratories L.P. | Meals · 2025-06-02 | Nemluvio | $10 |
| Galderma Laboratories L.P. | Meals · 2025-06-02 | Nemluvio | $6 |
| Janssen Biotech | Paid to speak or teach · 2025-05-31 | Tremfya | $4,050 |
| Galderma Laboratories L.P. | Travel · 2025-05-30 | Nemluvio | $45 |
| Galderma Laboratories L.P. | Meals · 2025-05-30 | Nemluvio | $14 |
| Galderma Laboratories L.P. | Travel · 2025-05-30 | Nemluvio | $44 |
| Janssen Biotech | Meals · 2025-05-28 | Tremfya | $143 |
| Ucb | Paid to speak or teach · 2025-05-28 | Bimzelx | $2,075 |
| Genzyme | Meals · 2025-05-28 | Dupixent | $45 |
| Janssen Biotech | Meals · 2025-05-27 | Tremfya | $17 |
| Novartis Pharmaceuticals | Meals · 2025-05-27 | Cosentyx | $34 |
| Amgen | Meals · 2025-05-27 | Otezla | $18 |
| Organon | Travel · 2025-05-27 | Vtama | $36 |
| Janssen Biotech | Meals · 2025-05-23 | Tremfya | $56 |
| Janssen Biotech | Travel · 2025-05-23 | Tremfya | $41 |
| Galderma Laboratories L.P. | Meals · 2025-05-22 | Nemluvio | $28 |
| LEO Pharma | Consulting · 2025-05-22 | Anzupgo | $900 |
| Regeneron Healthcare Solutions | Meals · 2025-05-21 | Dupixent | $27 |
| Galderma Laboratories L.P. | Paid to speak or teach · 2025-05-21 | Nemluvio | $3,600 |
| Abbvie | Meals · 2025-05-20 | Skyrizi | $21 |
| Pfizer | Meals · 2025-05-20 | Litfulo | $18 |
| LEO Pharma | Meals · 2025-05-20 | Adbry | $137 |
| Incyte | Meals · 2025-05-19 | Opzelura | $24 |
| Janssen Biotech | Paid to speak or teach · 2025-05-17 | Tremfya | $4,050 |
| Janssen Biotech | Meals · 2025-05-16 | Tremfya | $8 |
| Arcutis Biotherapeutics | Meals · 2025-05-16 | Zoryve | $21 |
| Janssen Biotech | Travel · 2025-05-15 | Tremfya | $938 |
| Galderma Laboratories L.P. | Meals · 2025-05-15 | Nemluvio | $35 |
| LEO Pharma | Consulting · 2025-05-15 | Adbry | $1,050 |
| Arcutis Biotherapeutics | Consulting · 2025-05-15 | Zoryve | $3,000 |
| Arcutis Biotherapeutics | Consulting · 2025-05-15 | Zoryve | $3,000 |
| Abbvie | Meals · 2025-05-14 | Rinvoq | $15 |
| Abbvie | Meals · 2025-05-13 | Skyrizi | $25 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-13 | Spevigo | $33 |
| Ucb | Meals · 2025-05-13 | Bimzelx | $9 |
| Ucb | Meals · 2025-05-13 | Bimzelx | $10 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-12 | Sotyktu | $23 |
| Genzyme | Meals · 2025-05-12 | Dupixent | $18 |
| Janssen Biotech | Paid to speak or teach · 2025-05-10 | Tremfya | $4,050 |
| Janssen Biotech | Paid to speak or teach · 2025-05-10 | Tremfya | $4,050 |
| Janssen Biotech | Paid to speak or teach · 2025-05-10 | Tremfya | $6,300 |
| Janssen Biotech | Meals · 2025-05-09 | Tremfya | $23 |
| Lilly USA | Meals · 2025-05-07 | Taltz | $21 |
| Abbvie | Meals · 2025-05-07 | Skyrizi | $27 |
| Organon | Honoraria · 2025-05-07 | Vtama | $3,200 |
| LEO Pharma | Meals · 2025-05-07 | Adbry | $18 |
| Janssen Biotech | Travel · 2025-05-06 | Tremfya | $1,492 |
| Janssen Biotech | Meals · 2025-05-06 | Tremfya | $118 |
| Lilly USA | Paid to speak or teach · 2025-05-05 | Ebglyss | $1,600 |
| Galderma Laboratories L.P. | Meals · 2025-05-05 | Nemluvio | $36 |
| Arcutis Biotherapeutics | Meals · 2025-05-05 | Zoryve | $13 |
| Arcutis Biotherapeutics | Meals · 2025-05-05 | Zoryve | $8 |
| Genzyme | Meals · 2025-05-01 | Dupixent | $125 |
| Organon | Honoraria · 2025-05-01 | Vtama | $3,200 |
| Lilly USA | Paid to speak or teach · 2025-04-30 | Ebglyss | $1,200 |
| Lilly USA | Paid to speak or teach · 2025-04-30 | Ebglyss | $3,200 |
| Amgen | Meals · 2025-04-30 | Otezla | $15 |
| Organon | Travel · 2025-04-30 | Vtama | $100 |
| Organon | Meals · 2025-04-30 | Vtama | $149 |
| Organon | Meals · 2025-04-30 | Vtama | $153 |
| Organon | Honoraria · 2025-04-30 | Vtama | $3,200 |
| Arcutis Biotherapeutics | Consulting · 2025-04-30 | Zoryve | $3,000 |
| Arcutis Biotherapeutics | Travel · 2025-04-30 | Zoryve | $462 |
| Arcutis Biotherapeutics | Travel · 2025-04-30 | Zoryve | $462 |
| Janssen Biotech | Meals · 2025-04-29 | Tremfya | $6 |
| Janssen Biotech | Travel · 2025-04-29 | Tremfya | $429 |
| Incyte | Meals · 2025-04-29 | Opzelura | $4 |
| Incyte | Meals · 2025-04-29 | Opzelura | $7 |
| Genzyme | Meals · 2025-04-29 | Dupixent | $32 |
| Janssen Biotech | Meals · 2025-04-28 | Tremfya | $31 |
| Lilly USA | Travel · 2025-04-28 | None | $321 |
| Abbvie | Meals · 2025-04-28 | Skyrizi | $16 |
| STRATA Skin Sciences | Meals · 2025-04-28 | Xtrac | $26 |
| Janssen Biotech | Paid to speak or teach · 2025-04-26 | Tremfya | $1,800 |
| Janssen Biotech | Paid to speak or teach · 2025-04-26 | Tremfya | $4,050 |
| Janssen Biotech | Meals · 2025-04-25 | Tremfya | $55 |
| Janssen Biotech | Meals · 2025-04-25 | Tremfya | $136 |
| Regeneron Healthcare Solutions | Meals · 2025-04-25 | Dupixent | $101 |
| Organon | Meals · 2025-04-23 | Vtama | $110 |
| Organon | Honoraria · 2025-04-23 | Vtama | $7,200 |
| LEO Pharma | Meals · 2025-04-23 | Adbry | $22 |
| Janssen Biotech | Travel · 2025-04-22 | Tremfya | $37 |
| Janssen Biotech | Meals · 2025-04-22 | Tremfya | $18 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-22 | Sotyktu | $30 |
| Abbvie | Meals · 2025-04-22 | Rinvoq | $26 |
| Pfizer | Meals · 2025-04-22 | Litfulo | $18 |
| Janssen Biotech | Paid to speak or teach · 2025-04-19 | Tremfya | $900 |
| Janssen Biotech | Travel · 2025-04-15 | Tremfya | $26 |
| Abbvie | Meals · 2025-04-15 | Skyrizi | $7 |
| Galderma Laboratories L.P. | Meals · 2025-04-15 | Nemluvio | $7 |
| Galderma Laboratories L.P. | Travel · 2025-04-15 | Nemluvio | $20 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-04-14 | Siliq | $25 |
| Janssen Biotech | Paid to speak or teach · 2025-04-12 | Tremfya | $4,050 |
| Ucb Sa | Consulting · 2025-04-11 | Bimzelx | $2,250 |
| Janssen Biotech | Meals · 2025-04-10 | Tremfya | $123 |
| Janssen Biotech | Travel · 2025-04-10 | Tremfya | $610 |
| Regeneron Healthcare Solutions | Meals · 2025-04-10 | Dupixent | $23 |
| Lilly USA | Meals · 2025-04-09 | Taltz | $32 |
| Abbvie | Meals · 2025-04-08 | Rinvoq | $14 |
| Ucb | Meals · 2025-04-08 | Bimzelx | $29 |
| Galderma Laboratories L.P. | Meals · 2025-04-08 | Nemluvio | $21 |
| Lilly USA | Paid to speak or teach · 2025-04-07 | Ebglyss | $1,600 |
| Abbvie | Paid to speak or teach · 2025-04-07 | Skyrizi | $3,500 |
| Janssen Biotech | Paid to speak or teach · 2025-04-05 | Tremfya | $4,050 |
| Galderma Laboratories L.P. | Paid to speak or teach · 2025-04-04 | Nemluvio | $3,600 |
| Abbvie | Paid to speak or teach · 2025-04-03 | Skyrizi | $3,500 |
| Galderma Laboratories L.P. | Meals · 2025-04-03 | Nemluvio | $30 |
| Lilly USA | Paid to speak or teach · 2025-04-02 | Ebglyss | $3,200 |
| Lilly USA | Paid to speak or teach · 2025-04-02 | Ebglyss | $1,200 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-04-02 | None | $4,788 |
| Janssen Biotech | Meals · 2025-04-01 | Tremfya | $145 |
| Janssen Biotech | Travel · 2025-04-01 | Tremfya | $802 |
| Arcutis Biotherapeutics | Meals · 2025-04-01 | Zoryve | $17 |
| Janssen Biotech | Meals · 2025-03-31 | Tremfya | $3 |
| Janssen Biotech | Meals · 2025-03-31 | Tremfya | $25 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-31 | Sotyktu | $13 |
| Lilly USA | Travel · 2025-03-31 | None | $377 |
| Lilly USA | Meals · 2025-03-31 | Ebglyss | $34 |
| Galderma Laboratories L.P. | Meals · 2025-03-28 | Nemluvio | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-03-26 | Dupixent | $28 |
| Abbvie | Paid to speak or teach · 2025-03-25 | Skyrizi | $3,500 |
| Janssen Biotech | Travel · 2025-03-24 | Tremfya | $8 |
| Janssen Biotech | Travel · 2025-03-24 | Tremfya | $86 |
| Janssen Biotech | Meals · 2025-03-24 | Tremfya | $7 |
| Janssen Biotech | Meals · 2025-03-24 | Tremfya | $26 |
| Lilly USA | Travel · 2025-03-24 | Ebglyss | $40 |
| Abbvie | Meals · 2025-03-24 | Skyrizi | $125 |
| Pfizer | Meals · 2025-03-24 | Litfulo | $27 |
| Janssen Biotech | Paid to speak or teach · 2025-03-22 | Tremfya | $1,800 |
| Janssen Biotech | Paid to speak or teach · 2025-03-22 | Tremfya | $1,800 |
| Janssen Biotech | Paid to speak or teach · 2025-03-22 | Tremfya | $1,700 |
| Organon | Meals · 2025-03-22 | Vtama | $36 |
| Organon | Meals · 2025-03-22 | Vtama | $53 |
| Organon | Meals · 2025-03-22 | Vtama | $53 |
| Organon | Meals · 2025-03-22 | Vtama | $66 |
| Organon | Travel · 2025-03-21 | Vtama | $197 |
| Organon | Travel · 2025-03-21 | Vtama | $210 |
| Organon | Travel · 2025-03-21 | Vtama | $513 |
| E.R. Squibb & Sons L.L.C. | Consulting · 2025-03-20 | None | $2,350 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-03-20 | Siliq | $20 |
| Lilly USA | Meals · 2025-03-19 | Taltz | $24 |
| Abbvie | Meals · 2025-03-19 | Skyrizi | $109 |
| Abbvie | Meals · 2025-03-19 | Skyrizi | $21 |
| Genzyme | Meals · 2025-03-19 | Dupixent | $17 |
| Organon | Travel · 2025-03-19 | Vtama | $111 |
| Organon | Meals · 2025-03-19 | Vtama | $201 |
| Eli Lilly and | Meals · 2025-03-18 | Ebglyss | $11 |
| Abbvie | Meals · 2025-03-18 | Rinvoq | $24 |
| Galderma Laboratories L.P. | Meals · 2025-03-18 | Nemluvio | $19 |
| Ucb | Meals · 2025-03-17 | Bimzelx | $16 |
| Arcutis Biotherapeutics | Meals · 2025-03-17 | Zoryve | $22 |
| Lilly USA | Paid to speak or teach · 2025-03-14 | Ebglyss | $1,200 |
| Lilly USA | Paid to speak or teach · 2025-03-14 | Ebglyss | $3,200 |
| Lilly USA | Travel · 2025-03-12 | Ebglyss | $36 |
| Abbvie | Meals · 2025-03-12 | Rinvoq | $17 |
| LEO Pharma | Meals · 2025-03-12 | Adbry | $27 |
| Lilly USA | Travel · 2025-03-11 | None | $377 |
| Lilly USA | Meals · 2025-03-11 | Ebglyss | $33 |
| Abbvie | Meals · 2025-03-11 | Skyrizi | $30 |
| Abbvie | Meals · 2025-03-11 | Skyrizi | $119 |
| Abbvie | Travel · 2025-03-11 | Skyrizi | $560 |
| Ucb | Paid to speak or teach · 2025-03-11 | Bimzelx | $2,075 |
| Janssen Biotech | Consulting · 2025-03-10 | Tremfya | $2,700 |
| Galderma Laboratories L.P. | Meals · 2025-03-10 | None | $13 |
| Amgen | Meals · 2025-03-09 | Otezla | $44 |
| Organon | Meals · 2025-03-09 | Vtama | $41 |
| Janssen Biotech | Paid to speak or teach · 2025-03-08 | Tremfya | $1,700 |
| Regeneron Healthcare Solutions | Meals · 2025-03-08 | Dupixent | $41 |
| Amgen | Meals · 2025-03-08 | Otezla | $44 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-07 | Sotyktu | $30 |
| Abbvie | Meals · 2025-03-07 | Skyrizi | $13 |
| Ucb | Meals · 2025-03-07 | None | $16 |
| Incyte | Meals · 2025-03-07 | Opzelura | $57 |
| Galderma Laboratories L.P. | Meals · 2025-03-07 | Nemluvio | $28 |
| LEO Pharma | Meals · 2025-03-07 | Adbry | $45 |
| Janssen Biotech | Travel · 2025-03-06 | Tremfya | $204 |
| Janssen Biotech | Meals · 2025-03-06 | Tremfya | $60 |
| Janssen Biotech | Travel · 2025-03-06 | Tremfya | $99 |
| Janssen Biotech | Meals · 2025-03-06 | Tremfya | $40 |
| Ortho Dermatologics a division of Bausch Health US | Paid to speak or teach · 2025-03-05 | Siliq | $1,800 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-03-05 | None | $3,192 |
| Ucb | Meals · 2025-03-04 | Bimzelx | $31 |
| Genzyme | Meals · 2025-03-04 | Dupixent | $24 |
| Lilly USA | Paid to speak or teach · 2025-03-03 | Ebglyss | $3,200 |
| Lilly USA | Paid to speak or teach · 2025-03-03 | Ebglyss | $1,200 |
| Novartis Pharmaceuticals | Meals · 2025-03-03 | Cosentyx | $7 |
| Abbvie | Meals · 2025-03-03 | Skyrizi | $5 |
| Organon | Meals · 2025-03-03 | Vtama | $22 |
| Abbvie | Meals · 2025-02-27 | Rinvoq | $30 |
| Lilly USA | Meals · 2025-02-26 | Ebglyss | $121 |
| Lilly USA | Travel · 2025-02-26 | None | $514 |
| LEO Pharma | Meals · 2025-02-26 | Adbry | $10 |
| Abbvie | Meals · 2025-02-25 | Skyrizi | $16 |
| Abbvie | Meals · 2025-02-25 | Skyrizi | $2 |
| Regeneron Healthcare Solutions | Meals · 2025-02-25 | Dupixent | $17 |
| Pfizer | Meals · 2025-02-25 | Litfulo | $27 |
| E.R. Squibb & Sons L.L.C. | Consulting · 2025-02-14 | None | $2,350 |
| E.R. Squibb & Sons L.L.C. | Consulting · 2025-02-14 | None | $588 |
| E.R. Squibb & Sons L.L.C. | Consulting · 2025-02-14 | None | $588 |
| Organon | Meals · 2025-02-13 | Vtama | $34 |
| Organon | Travel · 2025-02-13 | Vtama | $49 |
| Organon | Meals · 2025-02-13 | Vtama | $50 |
| Organon | Meals · 2025-02-13 | Vtama | $63 |
| Organon | Travel · 2025-02-13 | Vtama | $108 |
| Organon | Travel · 2025-02-13 | Vtama | $554 |
| Organon | Travel · 2025-02-13 | Vtama | $784 |
| Organon | Travel · 2025-02-12 | Vtama | $210 |
| Organon | Travel · 2025-02-12 | Vtama | $305 |
| Organon | Travel · 2025-02-12 | Vtama | $363 |
| Abbvie | Consulting · 2025-02-11 | Skyrizi | $775 |
| Arcutis Biotherapeutics | Meals · 2025-02-11 | Zoryve | $25 |
| Lilly USA | Meals · 2025-02-10 | Taltz | $14 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-02-10 | None | $1,050 |
| Galderma Laboratories L.P. | Paid to speak or teach · 2025-02-10 | Nemluvio | $2,700 |
| Janssen Biotech | Paid to speak or teach · 2025-02-08 | Tremfya | $1,700 |
| E.R. Squibb & Sons L.L.C. | Consulting · 2025-02-05 | None | $588 |
| Galderma Laboratories L.P. | Meals · 2025-02-05 | Nemluvio | $13 |
| Organon | Consulting · 2025-02-05 | Vtama | $7,020 |
| Organon | Consulting · 2025-02-05 | Vtama | $11,700 |
| Abbvie | Meals · 2025-02-04 | Skyrizi | $26 |
| Ucb | Paid to speak or teach · 2025-02-04 | Bimzelx | $1,660 |
| Genzyme | Meals · 2025-02-04 | Dupixent | $16 |
| Janssen Biotech | Meals · 2025-02-03 | Tremfya | $17 |
| Abbvie | Meals · 2025-02-03 | Skyrizi | $16 |
| Lilly USA | Meals · 2025-01-30 | Taltz | $35 |
| Abbvie | Meals · 2025-01-29 | Skyrizi | $3 |
| Abbvie | Meals · 2025-01-29 | Rinvoq | $10 |
| Incyte | Meals · 2025-01-29 | Opzelura | $31 |
| Amgen | Meals · 2025-01-29 | Otezla | $141 |
| Regeneron Healthcare Solutions | Meals · 2025-01-28 | Dupixent | $15 |
| Arcutis Biotherapeutics | Meals · 2025-01-28 | Zoryve | $16 |
| Pfizer | Meals · 2025-01-26 | Litfulo | $17 |
| Janssen Biotech | Paid to speak or teach · 2025-01-25 | Tremfya | $3,825 |
| Janssen Biotech | Travel · 2025-01-24 | Tremfya | $25 |
| Janssen Biotech | Meals · 2025-01-24 | Tremfya | $7 |
| Lilly USA | Meals · 2025-01-23 | Ebglyss | $17 |
| Janssen Biotech | Meals · 2025-01-22 | Tremfya | $121 |
| Janssen Biotech | Travel · 2025-01-22 | Tremfya | $738 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-22 | Sotyktu | $19 |
| Janssen Biotech | Meals · 2025-01-21 | Tremfya | $14 |
| Galderma Laboratories L.P. | Meals · 2025-01-21 | Nemluvio | $15 |
| Galderma Laboratories L.P. | Meals · 2025-01-21 | Nemluvio | $2 |
| Janssen Biotech | Meals · 2025-01-20 | Tremfya | $30 |
| Regeneron Healthcare Solutions | Meals · 2025-01-16 | Dupixent | $21 |
| Lilly USA | Meals · 2025-01-15 | Ebglyss | $77 |
| Lilly USA | Paid to speak or teach · 2025-01-15 | Ebglyss | $3,200 |
| Lilly USA | Paid to speak or teach · 2025-01-15 | Ebglyss | $2,000 |
| Lilly USA | Meals · 2025-01-15 | Ebglyss | $16 |
| Incyte | Meals · 2025-01-15 | Opzelura | $18 |
| Organon | Meals · 2025-01-15 | Vtama | $17 |
| Lilly USA | Paid to speak or teach · 2025-01-14 | Ebglyss | $3,200 |
| Abbvie | Meals · 2025-01-14 | Skyrizi | $32 |
| LEO Pharma | Meals · 2025-01-14 | Adbry | $11 |
| Organon | Meals · 2025-01-13 | Vtama | $4 |
| Lilly USA | Meals · 2025-01-12 | Taltz | $15 |
| Lilly USA | Meals · 2025-01-10 | Ebglyss | $28 |
| Lilly USA | Meals · 2025-01-10 | Ebglyss | $125 |
| Lilly USA | Travel · 2025-01-10 | None | $1,211 |
| Abbvie | Meals · 2025-01-10 | Rinvoq | $28 |
| Lilly USA | Paid to speak or teach · 2025-01-09 | None | $800 |
| Lilly USA | Meals · 2025-01-08 | Ebglyss | $80 |
| Genzyme | Meals · 2025-01-08 | Dupixent | $28 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-07 | Sotyktu | $25 |
| Abbvie | Meals · 2025-01-07 | Rinvoq | $19 |
| Ucb | Meals · 2025-01-07 | Bimzelx | $16 |
| Lilly USA | Paid to speak or teach · 2025-01-02 | None | $1,600 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $287,239
| Janssen Biotech | Tremfya | $59,239 | 67 payments
|
| Genzyme | Dupixent | $42,518 | 20 payments
|
| LEO Pharma | Adbry | $38,022 | 57 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $24,617 | 30 payments
|
| Arcutis Biotherapeutics | Zoryve | $20,588 | 20 payments
|
| Galderma Laboratories L.P. | None | $16,446 | 21 payments
|
| Pfizer | Cibinqo | $14,487 | 19 payments
|
| Lilly USA | Ebglyss | $13,752 | 45 payments
|
| Incyte | Opzelura | $13,563 | 18 payments
|
| Novartis Pharmaceuticals | Cosentyx | $11,916 | 6 payments
|
| Takeda Pharmaceuticals U.S.A. | None | $10,033 | 8 payments
|
| Zerigo Health | Clarify Medical | $5,250 | 1 payment
|
| Amgen | Otezla | $5,118 | 8 payments
|
| LEO Pharma AS | None | $3,800 | 1 payment
|
| Abbvie | Rinvoq | $3,027 | 53 payments
|
| Janssen Scientific Affairs | Tremfya | $1,800 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $1,123 | 14 payments
|
| Eli Lilly and | Taltz | $515 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $372 | 13 payments
|
| Sun Pharmaceutical Industries | Ilumya | $332 | 10 payments
|
| Ortho Dermatologics a division of Bausch Health US | Siliq | $235 | 9 payments
|
| Ucb | Bimzelx | $170 | 7 payments
|
| Dermavant Sciences | Vtama | $166 | 7 payments
|
| Avita Medical Americas | Recell | $59 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Siliq | $54 | 1 payment
|
| Regeneron Pharmaceuticals | Dupixent | $26 | 1 payment
|
| Biofrontera | Ameluz | $12 | 2 payments
|
2023: $98,171
| Genzyme | Dupixent | $28,474 | 24 payments
|
| Janssen Biotech | Tremfya | $17,888 | 24 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $11,697 | 3 payments
|
| Pfizer | Eucrisa | $8,560 | 2 payments
|
| LEO Pharma | Adbry | $8,495 | 13 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $6,930 | 5 payments
|
| Dermavant Sciences | Vtama | $5,979 | 6 payments
|
| Arcutis Biotherapeutics | None | $4,093 | 4 payments
|
| Ucb | Cimzia | $2,882 | 2 payments
|
| Lilly USA | Taltz | $1,668 | 2 payments
|
| AbbVie | Rinvoq | $744 | 3 payments
|
| Avita Medical Americas | Recell | $250 | 1 payment
|
| Amgen | Otezla | $243 | 4 payments
|
| Ortho Dermatologics a division of Bausch Health US | Siliq | $117 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $91 | 2 payments
|
| Sun Pharmaceutical Industries | Ilumya | $60 | 1 payment
|
2022: $35,181
| Janssen Biotech | Tremfya | $9,459 | 17 payments
|
| E.R. Squibb & Sons L.L.C. | None | $7,510 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $4,725 | 1 payment
|
| Ucb | None | $2,840 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | None | $2,734 | 4 payments
|
| LEO Pharma | Adbry | $1,900 | 1 payment
|
| Genzyme | Dupixent | $1,725 | 1 payment
|
| Mahana Therapeutics | None | $1,625 | 1 payment
|
| Abbvie | Rinvoq | $1,400 | 2 payments
|
| Pfizer | Eucrisa | $1,206 | 5 payments
|
| Lilly USA | Olumiant | $39 | 1 payment
|
| Celgene | None | $17 | 1 payment
|
2021: $19,532
| Boehringer Ingelheim Pharmaceuticals | None | $5,427 | 7 payments
|
| Ucb | None | $4,615 | 4 payments
|
| Boehringer Ingelheim International GmbH | None | $3,000 | 1 payment
|
| LEO Pharma | None | $2,740 | 1 payment
|
| Janssen Scientific Affairs | Tremfya | $2,400 | 1 payment
|
| Janssen Biotech | Tremfya | $1,350 | 1 payment
|
2020: $28,874
| Lilly USA | None | $7,700 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $4,950 | 2 payments
|
| Pfizer | None | $4,400 | 1 payment
|
| AbbVie | Humira | $4,319 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | None | $3,750 | 1 payment
|
| LEO Pharma | Enstilar | $2,055 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | None | $1,300 | 1 payment
|
| Clarify Medical | Clarify Home Light Therapy System | $400 | 1 payment
|
2019: $7,364
| Lilly USA | Taltz | $6,243 | 25 payments
|
| AbbVie | None | $1,050 | 1 payment
|
| LEO Pharma | Enstilar | $44 | 1 payment
|
| Amgen | Enbrel | $28 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Regeneron Pharmaceuticals, Inc. · The Impact of Dupilumab on Quality of Life in Moderate To Severe Atopic Dermatitis Patients · 2019 | Their institution | $271,271 |
| Novartis Pharmaceuticals Corporation · Evaluating Sleep in Patients With Moderate To Severe Psoriasis. · 2025 | Their institution | $132,972 |
| Novartis Pharmaceuticals Corporation · Evaluating Sleep in Patients With Moderate To Severe Psoriasis. · 2024 | Their institution | $132,972 |
| Regeneron Pharmaceuticals, Inc. · The Impact of Dupilumab on Quality of Life in Moderate To Severe Atopic Dermatitis Patients · 2022 | Their institution | $105,604 |
| Regeneron Pharmaceuticals, Inc. · The Impact of Dupilumab on Quality of Life in Moderate To Severe Atopic Dermatitis Patients · 2020 | Their institution | $90,518 |
| PFIZER INC. · A Phase 3 Openlabel Multicenter Longterm Study Investigating the Safety and Efficacy of Pf06651600 in Adult and Adolescent Participants With Alopecia Areata · 2021 | Their institution | $89,348 |
| Amgen Inc. · Efficacy/Safety Study of Apremilast in Subjects With Mild-To-Moderate Plaque Psoriasis (Psor-022) · 2020 | Their institution | $69,357 |
| Regeneron Pharmaceuticals, Inc. · The Impact of Dupilumab on Quality of Life in Moderate To Severe Atopic Dermatitis Patients · 2023 | Their institution | $57,363 |
| Dermavant Sciences, Inc. · An Open Label, Long-Term Extension Study To Evaluate the Safety and Efficacy of Tapinarof Cream 1% in Subjects With Atopic Dermatitis · 2023 | Their institution | $54,075 |
| Regeneron Pharmaceuticals, Inc. · The Impact of Dupilumab on Quality of Life in Moderate To Severe Atopic Dermatitis Patients · 2021 | Their institution | $48,878 |
| Mindera Corp · Match Study · 2022 | Their institution | $47,562 |
| Regeneron Pharmaceuticals, Inc. · An Open-Label Single-Arm Study of Dupilumab in Adolescent and Adult Skin of Color Patients With Moderate-To-Severe Atopic Dermatitis · 2023 | Their institution | $47,276 |
| PFIZER INC. · A Phase 3 Openlabel Multicenter Longterm Study Investigating the Safety and Efficacy of Pf06651600 in Adult and Adolescent Participants With Alopecia Areata · 2023 | Their institution | $43,968 |
| Dermavant Sciences, Inc. · An Open Label, Long-Term Extension Study To Evaluate the Safety and Efficacy of Tapinarof Cream 1% in Subjects With Atopic Dermatitis · 2024 | Their institution | $39,723 |
| Amgen Inc. · Ascend P3 Ad Extension · 2024 | Their institution | $38,284 |
| Janssen Research & Development, LLC · Phase 3 Multi Center Randomized Double Blind Placebo and Active Comparator Controlled Study Evaluating the Efficacy and Safety of Guselkumab in the Treatment of Subjects With Moderate To Severe Plaque Type Psoriasis · 2021 | Their institution | $37,691 |
| Janssen Research & Development, LLC · Phase 3, Multicenter, Randomized, Double-Blind, Placebo and Active Comparator-Controlled Study Evaluating the Efficacy and Safety of Guselkumab in the Treatment of Subjects With Moderate To Severe Plaque-Type Psoriasis · 2019 | Their institution | $34,958 |
| PFIZER INC. · A Phase 3 Openlabel Multicenter Longterm Study Investigating the Safety and Efficacy of Pf06651600 in Adult and Adolescent Participants With Alopecia Areata · 2022 | Their institution | $22,833 |
| Amgen Inc. · Horizon P3 Ad Monotherapy Induction · 2024 | Their institution | $22,807 |
| Mindera Corp · Mind.Px · 2021 | Their institution | $19,907 |
| Celgene Corporation · A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Study of the Efficacy and Safety of Apremilast (Cc-10004), Compared To Placebo, in Subjects Wtih Mild To Moderate Plaque Psoriasis (Cc-10004-Psor-022) · 2019 | Their institution | $19,278 |
| Merck Sharp & Dohme Corporation · A 52-Week, Phase 3, Randomized, Active Comparator and Placebo-Controlled, Parallel Design Study To Evaluate the Efficacy and Safety,Tolerability of Subcutaneous Sch 900222,Mk-3222, Followed By An Optional Long-Term Safety Extension Study, in Subjects With Moderate-To-Severe Chronic Plaque Psoriasis Protocol No. Mk-3222-011 · 2020 | Their institution | $18,613 |
| Janssen Research & Development, LLC · Cnto1959pso3017 · 2024 | Their institution | $18,504 |
| PFIZER INC. · A Phase 2b3 Randomized Doubleblind Placebocontrolled Doseranging Study To Investigate the Efficacy and Safety of Pf06651600 in Adult and Adolescent Alopecia Areata Aa Subjects With 50 Or Greater Scalp Hair Loss · 2021 | Their institution | $15,671 |
| Merck Sharp & Dohme Corporation · A 52-Week, Phase 3, Randomized, Active Comparator and Placebo-Controlled, Parallel Design Study To Evaluate the Efficacy and Safety,Tolerability of Subcutaneous Sch 900222,Mk-3222, Followed By An Optional Long-Term Safety Extension Study, in Subjects With Moderate-To-Severe Chronic Plaque Psoriasis Protocol No. Mk-3222-011 · 2019 | Their institution | $15,518 |
| Regeneron Pharmaceuticals, Inc. · An Open-Label Single-Arm Study of Dupilumab in Adolescent and Adult Skin of Color Patients With Moderate-To-Severe Atopic Dermatitis · 2024 | Their institution | $14,692 |
| PFIZER INC. · A Phase 3 Openlabel Multicenter Longterm Study Investigating the Safety and Efficacy of Pf06651600 in Adult and Adolescent Participants With Alopecia Areata · 2024 | Their institution | $14,476 |
| Eli Lilly and Company · An Open-Label Study To Evaluate the Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate-To-Severe Atopic Dermatitis Previously Treated With Dupilumab · 2023 | Their institution | $14,208 |
| Eli Lilly and Company · Multicenter, Double-Blind, Randomized, Placebo Controlled Study To Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 To Less Than 18 Years of Age With Moderate-To-Severe Plaque Psoriasis · 2019 | This clinician | $13,039 |
| Mindera Corp · Match Study · 2023 | Their institution | $12,940 |
| PFIZER INC. · A Phase 2b3 Randomized Doubleblind Placebocontrolled Doseranging Study To Investigate the Efficacy and Safety of Pf06651600 in Adult and Adolescent Alopecia Areata Aa Subjects With 50 Or Greater Scalp Hair Loss · 2020 | Their institution | $7,032 |
| Dermavant Sciences, Inc. · A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Moderate To Severe Atopic Dermatitis in Children With Adults · 2023 | Their institution | $6,833 |
| Amgen Inc. · Efficacy/Safety Study of Apremilast in Subjects With Mild-To-Moderate Plaque Psoriasis (Psor-022) · 2021 | Their institution | $5,620 |
| Dermavant Sciences, Inc. · An Open Label, Long-Term Extension Study To Evaluate the Safety and Efficacy of Tapinarof Cream 1% in Subjects With Atopic Dermatitis · 2022 | Their institution | $4,404 |
| PFIZER INC. · Abrocitinib Clinical Publication Program · 2021 | This clinician | $4,140 |
| Amgen Inc. · P3 Ad Monotherapy Induction · 2023 | Their institution | $3,346 |
| PFIZER INC. · Abrocitinib Clinical Publication Program · 2022 | This clinician | $3,200 |
| Amgen Inc. · A Study of the Efficacy and Safety of Apremilast Cc-10004 in Subjects With Moderate To Severe Plaque Psoriasis of the Scalp Style · 2019 | Their institution | $2,709 |
| PFIZER INC. · Abrocitinib Clinical Publication Program · 2020 | This clinician | $1,600 |
| Celgene Corporation · A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Study of the Efficacy and Safety of Apremilast (Cc-10004), Compared To Placebo, in Subjects Wtih Mild To Moderate Plaque Psoriasis · 2020 | Their institution | $252 |
| Amgen Inc. · A Study of the Efficacy and Safety of Apremilast (Cc-10004) in Subjects With Moderate To Severe Plaque Psoriasis of the Scalp (Style) · 2020 | Their institution | $252 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1144483124
- Licence
- CA A108915California A108915: Current · expires 2028-11-30
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 595 Buckingham Way Ste 220, San Francisco, CA, 94132
- NPI first listed
- 2008-07-09
- NPI last updated
- 2024-02-12
- NPI record certified
- 2024-02-12
This is when the NPI record was last certified, not a medical board exam.